전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved333 programs
CGTStandard DatabasestaleJuno Therapeutics, a Subsidiary…Phase 2

lisocabtagene maraleucel (JCAR017, JCAR017 (lisocabtagene maraleucel))

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 34Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

CAR T-Cell Infusion (CAR T-Cell Infusion)

Relapsed Acute Lymphoblastic Leukemia (ALL) · Leukemia

#Leukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 33Status Recruiting
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-T cells chimeric antigen receptor T cells (CAR-T cells chimeric antigen receptor T cells)

AML; Refractory/Relapse Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 33Status Recruiting
CGTStandard DatabasestaleMinsk Scientific-Practical Cent…Phase 2

CD19+22 CAR-T cells (CD19+22 CAR-T cells)

Acute Lymphobkastic Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 33Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

AP1903 (AP1903)

Leukemia; Myeloma · Sarcoma

#Sarcoma#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 32Status Recruiting
CGTStandard DatabasestalePersonGen BioTherapeutics (Suzh…Phase 2

anti-CD19 CAR-T cells (PCAR-019, PCAR-019 (anti-CD19 CAR-T cells))

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 32Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 1

Autologous CAR-T (Autologous CAR-T)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 31Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

CD70 CAR T-cells (CD70 CAR T-cells)

Metastatic Tumor; Renal Cell Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 31Status Active
CGTLimited DatastaleSyndax PharmaceuticalsPhase 1

Midostaurin (Midostaurin)

Acute Myeloid Leukemia; AML, Adult · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 31Status Recruiting
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

:Anti-CD22-CAR (:Anti-CD22-CAR)

Leukemia; Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTLimited DatastaleInstituto de Investigación Hosp…Phase 1

Autologous CD19/CD22 CAR T cells (Autologous CD19/CD22 CAR T cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastaleKara Lynn DavisPhase 1

Autologous CD22 CAR T (Autologous CD22 CAR T)

B Cell Lymphoma; Acute Lymphoblastic Leukemia, Pediatric · CD22

#CD22#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 30Status Active
CGTLimited DatastaleShanghai Simnova Biotechnology …Phase 1

CAR-NK-CD19 Cells (CAR-NK-CD19 Cells)

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTStandard DatabasestaleYake Biotechnology Ltd.Phase 2

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

B-Cell Acute Lymphoblastic Leukemia, Adult · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
AntibodyLimited DatastaleAlliance for Clinical Trials in…Phase 2

Epratuzumab (Epratuzumab)

Lymphoma · Leukemia

#Leukemia#Antibody#Phase2#monoclonal-antibody#Lymphoma+1
Trials 30Status Discontinued
ADCStandard DatabasestalePfizerPhase 3

Mylotarg (Gemtuzumab Ozogamicin, Gemtuzumab Ozogamicin (Mylotarg))

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#antibody-drug-conjugate#Pfizer
Trials 30Status Active
AntibodyLimited DatastaleJohn ReneauPhase 1

Mogamulizumab (Mogamulizumab)

Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma · Cutaneous T Cell Lymphoma

#CutaneousTCellLymphoma#Antibody#Phase1#monoclonal-antibody#RecurrentAdultT-CellLeukemia+3
Trials 30Status Recruiting
CGTStandard DatabasestaleKara Yakhteh Tajhiz Azma CompanyPhase 2

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Preclinical

anti-CD19-CAR vector-transduced T cells (anti-CD19-CAR vector-transduced T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 30Status Active
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Phase 1

anti-CD19/CD22 CAR-T cells (anti-CD19/CD22 CAR-T cells)

MRD-positive; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 28Status Active

3 / 17 pages

← PreviousNext →